Denali Therapeutics Inc. is seeking a senior DMPK leader to head the Nonclinical Safety Assessment and DMPK group, providing strategic vision for PK, drug disposition, and translational pharmacology across discovery to early clinical development.
You will guide SME-level decision-making, mentor staff, and collaborate with cross-functional teams to shape study designs and regulatory submissions. The role emphasizes leading cross-functional Project Teams, directing TK analyses for non-GLP/GLP
#J-18808-Ljbffr
Join us at Denali Therapeutics Inc as our next Director, DMPK & Translational PK Strategy in South San Francisco, CA, United States.
We are currently recruiting a Director, DMPK & Translational PK Strategy for our team in South San Francisco, CA, United States.
This is a strong role to take on the Director, DMPK & Translational PK Strategy role at Denali Therapeutics Inc.
As a Director, DMPK & Translational PK Strategy, you will play an important part at Denali Therapeutics Inc in South San Francisco, CA, United States.